MicroRNA biomarkers in lung cancer: MiRacle or quagMiRe?

Translational Research

Volumn 157, Issue 4, 2011, Pages 209-215

  Yendamuri, Sai ^a,b   Kratzke, Robert ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

computed tomography; CT; FFPE; formalin fixed paraffin embedded; RBC; real time polymerase chain reaction; red blood cell; RT PCR

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

BODY FLUID; COMPUTER ASSISTED TOMOGRAPHY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; LUNG CANCER; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW;

EID: 79952792906     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.12.015     Document Type: Review

References (48)

1. R.C. Lee, R.L. Feinbaum, and V. Ambros The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 75 1993 843 854 (Pubitemid 24014542)
2. G.A. Calin, C.D. Dumitru, and M. Shimizu Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc Natl Acad Sci U S A 99 2002 15524 15529 (Pubitemid 35403967)
3. S.M. Johnson, H. Grosshans, and J. Shingara RAS is regulated by the let-7 microRNA family Cell 120 2005 635 647 (Pubitemid 40343076)
4. N. Yanaihara, N. Caplen, and E. Bowman Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Cancer Cell 9 2006 189 198 (Pubitemid 43357945)
5. Y. Xi, G. Nakajima, and E. Gavin Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples RNA 13 2007 1668 1674 (Pubitemid 47481675)
6. S.K. Patnaik, E. Kannisto, S. Knudsen, and S. Yendamuri Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection Cancer Res 70 2010 36 45
7. M. Doleshal, A.A. Magotra, B. Choudhury, B.D. Cannon, E. Labourier, and A.E. Szafranska Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues J Mol Diagn 10 2008 203 211 (Pubitemid 351692162)
8. D.D. Taylor, and C. Gercel-Taylor MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer Gynecol Oncol 110 2008 13 21 (Pubitemid 351853251)
9. J.A. Weber, D.H. Baxter, and S. Zhang The microRNA spectrum in 12 body fluids Clinical Chem 56 2010 1733 1741
10. P.S. Mitchell, R.K. Parkin, and E.M. Kroh Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 105 2008 10513 10518
11. S.K. Patnaik, R. Mallick, and S. Yendamuri Detection of microRNAs in dried serum blots Anal Biochem 407 2010 147 149
12. C.J. Creighton, J.G. Reid, and P.H. Gunaratne Expression profiling of microRNAs by deep sequencing Brief Bioinform 10 2009 490 497
13. H. Wang, R.A. Ach, and B. Curry Direct and sensitive miRNA profiling from low-input total RNA RNA 13 2007 151 159 (Pubitemid 46026189)
14. J. Vandesompele, K. De Preter, and F. Pattyn Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 3 2002 RESEARCH0034
15. C.L. Andersen, J.L. Jensen, and T.F. Orntoft Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets Cancer Res 64 2004 5245 5250 (Pubitemid 39006544)
16. A. Gaur, D.A. Jewell, and Y. Liang Characterization of microRNA expression levels and their biological correlates in human cancer cell lines Cancer Res 67 2007 2456 2468 (Pubitemid 46548930)
17. H. Liu, P. D'Andrade, and S. Fulmer-Smentek mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities Mol Cancer Ther 9 2010 1080 1091
18. R.H. Shoemaker The NCI60 human tumour cell line anticancer drug screen Nat Rev Cancer 6 2006 813 823 (Pubitemid 44450469)
19. E.F. Patz Jr., N.E. Caporaso, and S.M. Dubinett National lung cancer screening trial American college of radiology imaging network specimen biorepository originating from the contemporary screening for the detection of lung cancer trial (nlst, acrin 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers J Thorac Oncol 5 2010 1502 1506
20. X. Chen, Y. Ba, and L. Ma Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases Cell Res 18 2008 997 1006
21. M.J. Lodes, M. Caraballo, and D. Suciu Detection of cancer with serum miRNAs on an oligonucleotide microarray PloS One 4 2009 e6229
22. G. Rabinowits, C. Gerel-Taylor, J.M. Day, D.D. Taylor, and G.H. Kloecker Exosomal microRNA: a diagnostic marker for lung cancer Clin Lung Cancer 10 2009 42 46
23. A. Keller, P. Leidinger, and A. Borries miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments BMC Cancer 9 2009 353
24. Van Pottelberge GR, Mestdagh P, Bracke KR, et al. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med.
25. S.Y. Chen, Y. Wang, M.J. Telen, and J.T. Chi The genomic analysis of erythrocyte microRNA expression in sickle cell diseases PloS One 3 2008 e2360
26. L. Xing, N.W. Todd, L. Yu, H. Fang, and F. Jiang Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers Mod Pathol 23 2010 1157 1164
27. L. Yu, N.W. Todd, and L. Xing Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers Int J Cancer 2010 Mar 2 [Epub ahead of print]
28. N. Rosenfeld, R. Aharonov, and E. Meiri MicroRNAs accurately identify cancer tissue origin Nat Biotechnol 26 2008 462 469 (Pubitemid 351501813)
29. R.G. Zinner, S. Novello, G. Peng, R. Herbst, C. Obasaju, and G. Scagliotti Comparison of patient outcomes according to histology among pemetrexed-treated patients with stage IIIB/IV non-small-cell lung cancer in two phase II trials Clin Lung Cancer 11 2010 126 131
30. R.S. Herbst, and A.B. Sandler Non-small cell lung cancer and antiangiogenic therapy: what can be expected of bevacizumab? Oncologist 9 Suppl 1 2004 19 26 (Pubitemid 38747844)
31. D. Lebanony, H. Benjamin, and S. Gilad Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma J Clin Oncol 27 2009 2030 2037
32. J.A. Bishop, H. Benjamin, H. Cholakh, A. Chajut, D.P. Clark, and W.H. Westra Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach Clin Cancer Res 16 2010 610 619
33. L. Du, J.J. Schageman, and Irnov MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs J Exp Clin Cancer Res 29 2010 75
34. I. Barshack, G. Lithwick-Yanai, and A. Afek MicroRNA expression differentiates between primary lung tumors and metastases to the lung Pathol Res Pract 206 2010 578 584
35. S.L. Yu, H.Y. Chen, and G.C. Chang MicroRNA signature predicts survival and relapse in lung cancer Cancer Cell 13 2008 48 57
36. M. Raponi, L. Dossey, and T. Jatkoe MicroRNA classifiers for predicting prognosis of squamous cell lung cancer Cancer Res 69 2009 5776 5783
37. W. Gao, Y. Yu, and H. Cao Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis Biomed Pharmacoth 64 2010 399 408
38. M.T. Landi, Y. Zhao, and M. Rotunno MicroRNA expression differentiates histology and predicts survival of lung cancer Clin Can Res 16 2010 430 441
39. Z. Hu, X. Chen, and Y. Zhao Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer J Clin Oncol 28 2010 1721 1726
40. J. Voortman, A. Goto, and J. Mendiboure MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma Cancer Res 70 2010 8288 8298
41. P.E. Blower, J.S. Verducci, and S. Lin MicroRNA expression profiles for the NCI-60 cancer cell panel Mol Cancer Ther 6 2007 1483 1491 (Pubitemid 46954015)
42. P.E. Blower, J.H. Chung, and J.S. Verducci MicroRNAs modulate the chemosensitivity of tumor cells Mol Cancer Ther 7 2008 1 9
43. W. Kong, L. He, and M. Coppola MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer J Biol Chem 285 2010 17869 17879
44. Z.W. Yu, L.P. Zhong, T. Ji, P. Zhang, W.T. Chen, and C.P. Zhang MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines Oral Oncol 46 2010 317 322
45. L. Xie, X. Chen, and L. Wang Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions BMC Cancer 10 2010 591
46. J.H. Hwang, J. Voortman, and E. Giovannetti Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer PloS One 5 2010 e10630
47. A.R. Ranade, D. Cherba, and S. Sridhar MicroRNA 92a-2: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer J Thorac Oncol 5 2010 1273 1278
48. J.K. Lee, D.M. Havaleshko, and H. Cho A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery Proc Natl Acad Sci U S A 104 2007 13086 13091 (Pubitemid 351737597)